Stephens Reaffirms “Overweight” Rating for Encompass Health (NYSE:EHC)

Stephens reaffirmed their overweight rating on shares of Encompass Health (NYSE:EHC – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $94.00 price objective on the stock. Several other research firms have also recently commented on EHC. Royal Bank of Canada lifted their target price on Encompass […]

Leave a Reply

Your email address will not be published.

Previous post Charles River Laboratories International (NYSE:CRL) Lifted to Buy at StockNews.com
Next post Digi International Inc. (NASDAQ:DGII) Receives $36.50 Average PT from Analysts